Edition:
India

Profile: Aurobindo Pharma Ltd (ARBN.BO)

ARBN.BO on Bombay Stock Exchange

664.20INR
3:53pm IST
Change (% chg)

Rs-6.05 (-0.90%)
Prev Close
Rs670.25
Open
Rs681.00
Day's High
Rs683.75
Day's Low
Rs658.00
Volume
202,771
Avg. Vol
150,894
52-wk High
Rs838.00
52-wk Low
Rs527.05

Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.

Company Address

Aurobindo Pharma Ltd

Water Mark Building,, Plot No. 1
Survey no.9, Kondapur, Hitech Ci
Hyderabad,Telangana
HYDERABAD     500084
P: +9140.66725000
F: +9140.23741080

Company Web Links